James Goodrich
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Antifungal resistance and susceptibility
Papers in
-
- HIV/AIDS drug development and treatment 15
- HIV/AIDS Research and Interventions 11
- Virology 18
- HIV Research and Treatment 18
- Co-authors
- Howard Mayer (8 shared papers)Roy M. Gulick (4 shared papers)Elna van der Ryst (4 shared papers)Nathan Clumeck (2 shared papers)Bonaventura Clotet (2 shared papers)John F. Sullivan (2 shared papers)Jacob Lalezari (2 shared papers)Jeffrey P. Nadler (1 shared paper)
- Journals
- JAIDS Journal of Acquired Immune Deficiency Syndromes (5 papers)Journal of the International AIDS Society (2 papers)The Journal of Infectious Diseases (2 papers)Clinical Therapeutics (2 papers)HIV Clinical Trials (2 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
James Goodrich
30 papers receiving 1.7k citations
James Goodrich's Hit Papers
Peers
Comparison fields: 5 of 83
- Virology 1.1k
- Infectious Diseases 1.1k
- Emergency Medicine 186
- Epidemiology 533
- Hepatology 100
Countries citing papers authored by James Goodrich
This map shows the geographic impact of James Goodrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Goodrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Goodrich more than expected).
Fields of papers citing papers by James Goodrich
This network shows the impact of papers produced by James Goodrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Goodrich. The network helps show where James Goodrich may publish in the future.
Co-authors
The 25 scholars most cited alongside James Goodrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Maraviroc for Previously Treated Patients with R5 HIV-1 Infection Hit paper breakdown → | 2008 | 570 |
| 2 | 2005 | 221 | |
| 3 | 1990 | 166 | |
| 4 | 2016 | 113 | |
| 5 | 2009 | 108 | |
| 6 | 1997 | 93 | |
| 7 | 2010 | 72 | |
| 8 | 2010 | 61 | |
| 9 | 2010 | 49 | |
| 10 | 2011 | 42 | |
| 11 | 2010 | 39 | |
| 12 | 2013 | 31 | |
| 13 | Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation. | 1994 | 30 |
| 14 | 2012 | 25 | |
| 15 | 2013 | 16 | |
| 16 | 2013 | 15 | |
| 17 | 2008 | 15 | |
| 18 | Adoptive immunotherapy of human cytomegalovirus infection: potential role in protection from disease progression. | 1991 | 14 |
| 19 | 2016 | 13 | |
| 20 | 2010 | 12 |
About James Goodrich
James Goodrich is a scholar working on Infectious Diseases, Virology, Epidemiology, Emergency Medicine and Public Health, Environmental and Occupational Health, having authored 32 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (15 papers), HIV/AIDS Research and Interventions (11 papers), HIV-related health complications and treatments (5 papers), Cytomegalovirus and herpesvirus research (4 papers), Mosquito-borne diseases and control (3 papers), Tissue Engineering and Regenerative Medicine (2 papers) and Fungal Infections and Studies (2 papers). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (1.1k citations), Emergency Medicine (186 citations), Epidemiology (533 citations) and Hepatology (100 citations). James Goodrich has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Howard Mayer, Roy M. Gulick, Elna van der Ryst, Nathan Clumeck, Bonaventura Clotet, John F. Sullivan, Jacob Lalezari, Jeffrey P. Nadler, Steve Felstead and Andrzej Horban. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, Journal of the International AIDS Society, The Journal of Infectious Diseases, Clinical Therapeutics and HIV Clinical Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.